Ascentage Pharma Group International (6855.HK) HKSE

62.45

+1.6(+2.63%)

Updated at December 05 01:41PM

Currency In HKD

Valuation

Market Cap12.89B
Enterprise Value13.3B
P/E Ratio-16.62
PEG Ratio0.09
Price/Sales Ratio53.71
Price/Book Ratio28.93
Enterprise/Revenue53.85
Enterprise/EBITDA-20.13

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-2.97
Operating Margin-2.87

Management Effectiveness

Return On Assets-0.38
Return On Equity-2.49

Income Statement

Revenue980.65M
Revenue/Share1.14
Gross Profit951.57M
EBITDA-299.63M
Net Income-405.43M
Diluted EPS-1.34

Balance Sheet

Total Cash1.66B
Total Cash/Share4.87
Total Debt1.72B
Total Debt/Equity2.58
Current Ratio1.54
Book Value Per Share1.98

Price History

52-Week Change50.48
52-Week High95.35
52-Week Low31.35
Moving Average 50 Days67.87
Moving Average 200 Days62.07

Statistics

Average Volume2.19M
Shares Outstanding371.85M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A